These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8307456)

  • 21. Improving the diagnosis and management of GORD in adults.
    Hopper AD
    Practitioner; 2015 Apr; 259(1781):27-32, 3. PubMed ID: 26529827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Famotidine in the management of gastro-oesophageal reflux.
    Okoth FA; Lule GN; Ogutu EO; Pilczer S; Dubois C
    East Afr Med J; 1994 Jan; 71(1):44-8. PubMed ID: 8055765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of gastro-oesophageal reflux.
    Carré IJ
    Arch Dis Child; 1985 Jan; 60(1):71-5. PubMed ID: 3970577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of omeprazole or anti-reflux surgery on lower oesophageal sphincter characteristics and oesophageal acid exposure over 10 years.
    Emken BG; Lundell LR; Wallin L; Myrvold HE; Engström C; Montgomery M; Malm AR; Lind T; Hatlebakk JG;
    Scand J Gastroenterol; 2017 Jan; 52(1):11-17. PubMed ID: 27593706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acid reflux and gastro-oesophageal reflux disease.
    Watson AR; Bowling TE
    Br J Community Nurs; 2004 Aug; 9(8):326-30. PubMed ID: 15365470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
    Bretagne JF; Rey JF; Caekaert A; Barthélemy P
    Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac mucosa at the gastro-oesophageal junction: indicator of gastro-oesophageal reflux disease? Data from a prospective central European multicentre study on histological and endoscopic diagnosis of oesophagitis (histoGERD trial).
    Langner C; Schneider NI; Plieschnegger W; Schmack B; Bordel H; Höfler B; Eherer AJ; Wolf EM; Rehak P; Vieth M
    Histopathology; 2014 Jul; 65(1):81-9. PubMed ID: 24393213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. There is no correlation between signs of reflux laryngitis and reflux oesophagitis in patients with gastro-oesophageal reflux disease symptoms.
    Zelenik K; Kajzrlikova IM; Vitek P; Urban O; Hanousek M; Kominek P
    Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):401-405. PubMed ID: 29165435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission.
    Oudkerk Pool M
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():13-6. PubMed ID: 18081644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.
    Ando T; El-Omar EM; Goto Y; Nobata K; Watanabe O; Maeda O; Ishiguro K; Minami M; Hamajima N; Goto H
    Gut; 2006 Feb; 55(2):158-64. PubMed ID: 16120761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications of gastro-oesophageal reflux disease.
    Parasa S; Sharma P
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):433-42. PubMed ID: 23998980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing gastro-oesophageal reflux in infants.
    Drug Ther Bull; 2009 Dec; 47(12):134-7. PubMed ID: 20009040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of gastro-oesophageal reflux disease.
    Petersen H
    Scand J Gastroenterol Suppl; 1995; 211():5-6. PubMed ID: 8545631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current approaches in the medical treatment of oesophageal reflux.
    Richter JE; Castell DO
    Drugs; 1981 Apr; 21(4):283-91. PubMed ID: 7014172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.